It is not unless you already have your pre-diabetic, your diabetic insulin, as a concern For a healthy individual who's active
This common question arises among patients starting glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
Abe C, Miyazawa T, Miyazawa T
This is consistent with the known side effect profile of GLP-1 medications, where headaches appear in a meaningful minority of patients during dose initiation and escalation phases
Conclusion: A Promising Future for Cardiovascular Health Semaglutide has become a game-changer in the management of both diabetes and weight loss
Ro empowers patients to connect with a licensed provider and, if appropriate, determine which GLP-1 is the best option based on their insurance coverage, the cost, and their unique clinical needs and health goals whether they're just getting started or in search of a maintenance option